Open AccessNodular primary cutaneous melanoma is associated with PD-L1 expression
Author(s) -
Mara Giavina-Bianchi,
Pedro GiavinaBianchi,
Mírian N. Sotto,
Scott J. Rodig,
Martín C. Mihm,
Cyro Festa Neto,
Lyn M. Duncan,
Jorge Kalil
Publication year - 2020
Publication title -
european journal of dermatology/ejd. european journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.48
H-Index - 71
eISSN - 1952-4013
pISSN - 1167-1122
DOI - 10.1684/ejd.2020.3846
Subject(s) - medicine , melanoma , immunohistochemistry , foxp3 , tumor infiltrating lymphocytes , cd8 , pathology , population , adjuvant therapy , phototype , biopsy , nodular melanoma , oncology , cancer , immune system , immunology , cancer research , dermatology , environmental health
In previous studies, patients with Stage III melanomas expressing PD-L1 in more than 5% of their neoplastic cells had improved recurrence-free survival with anti-PD1 adjuvant therapy.